Palvella Therapeutics (PVLA) Preferred Dividend Payments (2024)
Palvella Therapeutics (PVLA) posted quarterly Preferred Dividend Payments of -$582000.0 for Q4 2024, down 400.0% quarter-over-quarter from $194000.0 in Q3 2024.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Preferred Dividend Payments (2024) Analysis & Trends
Palvella Therapeutics (PVLA) has reported Preferred Dividend Payments for 1 consecutive years, with -$582000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Preferred Dividend Payments changed N/A year-over-year to -$582000.0; the TTM figure through Sep 2025 stood at -$582000.0 (changed N/A YoY), while the FY2023 annual figure was $776000.0, changed N/A from the prior year.
- Preferred Dividend Payments eased to -$582000.0 in Q4 2024 per PVLA's latest filing, from $194000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $194000.0 in Q1 2024 and bottomed at -$582000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Palvella Therapeutics | 2.24 Bn | 1.93 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -582,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 194,000.00 |